PGNY (Progyny, Inc.) Stock Financials & Earnings

PGNYProgyny, Inc.

Mkt Cap$1B

Revenue (TTM)$1.3B

Net Income (TTM)$59M

EPS (TTM)$0.65

Free Cash Flow (TTM)$189M

Gross Margin23.6%

Op. Margin6.6%

Net Margin4.5%

FCF Margin14.6%

P/S Ratio (TTM)1.1x

P/E Ratio (TTM)25.3x

YoY Rev Growth+10.4%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$258M	$59M	$15M
Q2 23	$279M	$61M	$15M
Q3 23	$281M	$63M	$18M
Q4 23	$270M	$57M	$14M
Q1 24	$278M	$62M	$19M
Q2 24	$304M	$68M	$21M
Q3 24	$287M	$59M	$12M
Q4 24	$298M	$63M	$16M
Q1 25	$324M	$76M	$24M
Q2 25	$333M	$79M	$24M
Q3 25	$313M	$73M	$22M
Q4 25	$318M	$77M	$15M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Quarter	Fertility benefit services revenue	Pharmacy benefit services revenue
Q1 23	$157M	$101M
Q2 23	$173M	$107M
Q3 23	$175M	$106M
Q4 23	$171M	$99M
Q1 24	$170M	$108M
Q2 24	$194M	$111M
Q3 24	$179M	$108M
Q1 25	$206M	$118M
Q2 25	$214M	$119M
Q3 25	$202M	$111M
Q4 25	$209M	$110M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$155M	$53M	$208M
Q2 23	$171M	$112M	$282M
Q3 23	$158M	$177M	$336M
Q4 23	$97M	$274M	$371M
Q1 24	$115M	$257M	$372M
Q2 24	$95M	$167M	$262M
Q3 24	$91M	$144M	$236M
Q4 24	$162M	$66M	$228M
Q1 25	$109M	$147M	$256M
Q2 25	$133M	$173M	$305M
Q3 25	$134M	$211M	$345M
Q4 25	$112M	$198M	$310M

Shares Outstanding

Revenue Per Employee

Revenue / Employee